Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rhinovirus transmission
01
Overview
Rhinovirus transmission" refers to the process by which rhinovirus particles, primarily responsible for the common cold, are spread among individuals. Human rhinoviruses are transmitted through respiratory aerosols, droplets, contaminated surfaces (fomites), and direct person-to-person contact. The virus uses cell surface receptors such as ICAM-1, LDLR, and CDHR3 to infect respiratory epithelial cells. Environmental stability of the virus and its ability to remain infectious on surfaces for hours increase the likelihood of transmission. Transmission can be reduced by airborne precautions, hand washing, and disinfecting surfaces[1][4][5][6].
02
Disease associations
Infection
Beyond the preview
Go deeper on Rhinovirus transmission.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rhinovirus transmission.